IBSA USA
Laura Gubitosi (Fernandez), MHRM, SPHR, currently serves as HR Manager at IBSA USA since June 2022. Prior experience includes positions at Reproductive Medicine Associates (RMA Network) from November 2015 to June 2022, where roles included HRIS Manager and Senior Human Resources Generalist, among others. Laura's career began at Robert Wood Johnson University Hospital as a Dietary Worker from May 2013 to February 2015. Additional internships and roles include a Compliance Intern at Global Aerospace and a Teaching Assistant at Rutgers University. Laura holds a Master of Arts in Human Resources Management and a Bachelor of Arts in Human Resource Management, both from Rutgers University.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.